Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients

European Journal of Cancer

Volumn 34, Issue 8, 1998, Pages 1213-1218

  Sersa G ^a   Stabuc B ^a   Cemazar M ^a   Jancar B ^a   Miklavcic D ^b   Rudolf, Z ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Basal cell carcinoma; Cisplatin; Drug delivery system; Electrochemotherapy; Electroporation; Melanoma; Squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER THERAPY; CASE REPORT; ELECTROCHEMOTHERAPY; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MALE; MELANOMA; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ELECTRIC STIMULATION THERAPY; ELECTROPORATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0032126313     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00025-2     Document Type: Article

References (31)

1. 1. Langer R. New methods of drug delivery. Science 1990, 249, 1527-1533.
2. 2. Mir LM, Orlowski S, Belehradek J Jr, et al. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem Bioenerg 1995, 38, 203-207.
3. 3. Rols MP, Teissie J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990, 58, 1089-1098.
4. 4. Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993, 1154, 51-63.
5. 5. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmac 1996, 27, 745-748.
6. 6. Melvik JE, Pettersen EO, Gordon PB, Selgen PO. Increase in cisdichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured on human NHIK 3025 cells. Eur J Cancer Clin Oncol 1996, 22, 1523-1530.
7. 7. Serša G, Čemažar M, Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995, 55, 3450-3455.
8. 8. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991, 42, S67-S75.
9. 9. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electrical conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992, 83, 1095-1101.
10. 10. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991, 27, 68-72.
11. 11. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PC, Mir LM. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochim Biophys Res Commun 1993, 194, 938-943.
12. 12. Serša G, Čemažar M, Miklavčič D, Mir LM. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem Bioenerg 1994, 35, 23-27.
13. 13. Heller R, Jaroszeski M, Messina J, et al. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem Bioenerg 1995, 36, 83-87.
14. 14. Rudolf Z, Štabuc B, Čemažar M, Miklavčič D, Vodovnik L, Serša G. Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol Oncol 1995, 29, 229-235.
15. 15. Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy. New advances in the clinical protocol. Cancer 1996, 77, 956-963.
16. 16. Heller R, Jaroszeski M, Glass F, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996, 77, 964-971.
17. 17. Čemažar M, Miklavčič D, Vodovnik L, et al. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice. Radiol Oncol 1995, 29, 121-127.
18. 18. Serša G, Čemažar M, Miklavčič D. Potentiation of CDDP antitumor effectiveness by electric pulses. Proc Anno Meet Am Assoc Cancer Res 1997, 38, 260.
19. 19. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, WHO Offset Publications, 1979, 48, 22-27.
20. 20. Begg AC, Bartelink H, Stewart FA, Brown DM, Luck EE. Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system. NCI Monogr 1988, 6, 133-136.
21. 21. De Vita Jr VT, Hellman S, Rosenberg SA. Biologic Therapy of Cancer. Philadelphia, Lippincott, 1991.
22. 22. Lübbe AS, Bergemann C, Riess H, et al. Clinical experience with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996, 56, 4686-4693.
23. 23. Steerenberg PA, Storm G, Groot G de, et al. Liposomes as a drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother Pharmacol 1988, 21, 299-307.
24. 24. Vadiei K, Siddik ZH, Khokhar AR, Al-Baker S, Sampadero F, Perez-Soler R. Pharmacokinetics of liposome-entrapped cis-bisneodecanoato-trans-R,R-1,2-diamminecyclohexaneplatinum (II) and cisplatin given i.v. and i.p. in the rat. Cancer Chemother Pharmacol 1992, 30, 365-369.
25. 25. Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D, Howell SB. Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 1993, 45, 2079-2085.
26. 26. Serša G, Čemažar M, Šemrov D, Miklavčič D. Changing electrode orientation improves the efficacy of electrochemotherapy on solid tumors in mice. Bioelectrochem Bioenerg 1996, 39, 61-66.
27. 27. Jaroszeski M, Gilbert R, Perrott R, Heller R. Enhanced effects of multiple treatment electrochemotherapy. Melanoma Res 1996, 6, 427-433.
28. 28. Gilbert R, Jaroszeski M, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997, 1334, 9-14.
29. 29. Mir LM, Devauchelle P, Quintin-Colonna F, et al. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 1997, 76, 1617-1622.
30. 30. Reintgen DS, Jaroszeski MJ, Heller R. Electrochemotherapy, a novel approach to cancer. Skin Cancer Foundation J 1996, 14, 17-19, 83.
31. 31. Serša G, Beravs K, Čemažar M, Miklavčič D, Demšar F. Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro Magnetobiol 1998, 17, 297-304.